Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Tang

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Elife|August 10, 2019
USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replicationTing Pan, Zheng Song, Liyang Wu, et al.
Chinese Medical Journal|January 4, 2014
An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in ChinaTaisheng Li, Fuping Guo, Yijia Li, et al.
EMBO Reports|June 1, 2022
CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2Liyang Wu, Ting Pan, Mo Zhou, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Unraveling the HGF/MET axis in Mallory-Denk body pathogenesis associated with liver fibrosis through single-cell transcriptomicsXiaoping Tang, Yi Shi, Jia Pan, et al.
Cellular & Molecular Immunology|October 10, 2020
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tractFengyu Hu, Fengjuan Chen, Zhihua Ou, et al.
The Journal of Clinical Investigation|August 10, 2021
Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1Bingfeng Liu, Wanying Zhang, Baijin Xia, et al.
National Science Review|November 3, 2022
Characteristics of SARS-CoV-2 Delta variant-infected individuals with intermittently positive retest viral RNA after dischargeLu Li, Jingyan Tang, Zhiwei Xie, et al.
Nature Communications|November 15, 2023
Interferon stimulated immune profile changes in a humanized mouse model of HBV infectionYaping Wang, Liliangzi Guo, Jingrong Shi, et al.
Elife|January 18, 2019
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFbXiancai Ma, Tao Yang, Yuewen Luo, et al.
Journal of Medical Virology|January 12, 2021
Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysisKai Deng, Qinghong Fan, Yanhong Yang, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Elife|August 10, 2019
USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replicationTing Pan, Zheng Song, Liyang Wu, et al.
Chinese Medical Journal|January 4, 2014
An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in ChinaTaisheng Li, Fuping Guo, Yijia Li, et al.
EMBO Reports|June 1, 2022
CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2Liyang Wu, Ting Pan, Mo Zhou, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Unraveling the HGF/MET axis in Mallory-Denk body pathogenesis associated with liver fibrosis through single-cell transcriptomicsXiaoping Tang, Yi Shi, Jia Pan, et al.
Cellular & Molecular Immunology|October 10, 2020
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tractFengyu Hu, Fengjuan Chen, Zhihua Ou, et al.
The Journal of Clinical Investigation|August 10, 2021
Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1Bingfeng Liu, Wanying Zhang, Baijin Xia, et al.
National Science Review|November 3, 2022
Characteristics of SARS-CoV-2 Delta variant-infected individuals with intermittently positive retest viral RNA after dischargeLu Li, Jingyan Tang, Zhiwei Xie, et al.
Nature Communications|November 15, 2023
Interferon stimulated immune profile changes in a humanized mouse model of HBV infectionYaping Wang, Liliangzi Guo, Jingrong Shi, et al.
Elife|January 18, 2019
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFbXiancai Ma, Tao Yang, Yuewen Luo, et al.
Journal of Medical Virology|January 12, 2021
Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysisKai Deng, Qinghong Fan, Yanhong Yang, et al.
Pageof 25